Medicus Pharma Ltd. Common Stock (MDCX) is a publicly traded Healthcare sector company. As of September 4, 2026, MDCX trades at $0.17 with a market cap of $16.42M and a P/E ratio of -0.07. MDCX moved +4.57% today. Year to date, MDCX is -89.34%; over the trailing twelve months it is -90.68%. Its 52-week range spans $0.15 to $8.94. Analyst consensus is strong buy with an average price target of $3.97. Rallies surfaces MDCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MDCX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.17 |
| Market Cap | $16.42M |
| P/E Ratio | -0.07 |
| EPS | $-2.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.94 |
| 52-Week Low | $0.15 |
| Volume | 7.34M |
| Avg Volume | 0 |
| Revenue (TTM) | $-261.25K |
| Net Income | $-44.89M |
| Gross Margin | 0.00% |
3 analysts cover MDCX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.97.